Conscience publishes first Annual Report
Conscience has published its latest Annual Report, highlighting a year of progress in advancing open science drug discovery and building the foundations for long-term impact across the research and innovation ecosystem. In 2025, Conscience moved from concept to execution, funding the first projects through the Developing Medicines through Open Science (DMOS) program, expanding the CACHE […]
Conscience sparks dialogue on open science at the Fonds de solidarité FTQ Life Sciences Symposium
A few weeks ago, Conscience’s Chief Science Officer Aled Edwards and board member Florence Rozen—who also serves as Scientific Director of Investments at the Fonds de solidarité FTQ—participated in a standout panel on open science at the Fonds’ invitation-only Life Sciences Symposium in Montréal. The event marked the Fonds’ 35-year commitment to innovation in Québec’s […]
Announcing a Leadership Transition at Conscience
As we approach the start of a new year, we’re announcing an important transition for Conscience – we are seeking a new CEO and a Director of Program Operations to join our leadership team, and take the organization into the future. Our inaugural CEO, Ryan Merkley, has resigned to pursue a new opportunity, and we […]
AstraZeneca joins CACHE Governing Board
We are pleased to announce that AstraZeneca, a global, science-led biopharmaceutical company has joined the CACHE (Critical Assessment of Computational Hit-finding Experiments) Governing Board for a two-year term, which is a critical element of Conscience’s efforts to set clear industry-leading benchmarks and improve success rates in the current drug discovery system. Bringing a wealth of […]
Will AI Expertise Push Canada Forward As A Biopharma Hub?
In Canada, an impressive roster of machine learning companies and institutions highlights the research being conducted there. However, a paucity of VC funding and few experienced C-suite leaders has stunted the commercialization of great ideas. Read the full article on invivo.citeline.com.
